Underground Psilocybin Therapy Healed My TBI—Here’s My Story!

A journey with psilocybin for Traumatic Brain Injury….

Introduction

In the quiet shadows of the healthcare system, there are people taking incredible risks in pursuit of healing. People like Patient X, who found themselves abandoned by conventional treatments and forced to look beyond the boundaries of legality to reclaim their life after a traumatic brain injury (TBI). This is their story; one of desperation, courage, and hope, and a stark reminder that the current system is failing too many people.

Since psilocybin treatment is not legal in the United Kingdom, we have decided to use a pseudonym to protect the individual’s privacy. They wish to share their story without self-incrimination. Therefore, they will be referred to as Patient X henceforth.

🧠 What is a Traumatic Brain Injury?

Before we explore Patient X and their story, it is important to explore what a traumatic brain injury. A Traumatic Brain Injury (TBI) is a condition resulting from an external force applied to the brain, such as a blow, jolt, or penetrating injury to the head. The severity of TBIs can vary, ranging from mild (concussions) to severe (prolonged loss of consciousness or enduring cognitive and physical impairments).

TBIs impact brain functionality sometimes temporarily and other times permanently and may arise from incidents such as:

Falls
Car accidents
Sports injuries
Assaults
Military blasts or explosions

⚠️ Signs and Symptoms of Traumatic Brain Injury

Symptoms of a Traumatic Brain Injury (TBI) can vary depending on severity, location of injury, and individual factors. These symptoms may present themselves immediately or manifest over several hours or days. Below is a comprehensive list, categorised accordingly:

Physical Symptoms:

Headache (persistent or worsening)
Nausea or vomiting
Fatigue or drowsiness
Fainting
Loss of consciousness (seconds to hours)
Loss of motor functions
Loss of co-ordination
Dizziness or balance problems
Sensitivity to light or noise
Blurred or double vision
Ringing in the ears (tinnitus)
Seizures or convulsions
Clear fluid draining from the nose or ears (cerebrospinal fluid)
Weakness or numbness in fingers and toes
Loss of coordination
Dilated pupils (in one or both eyes)

Cognitive and Mental Symptoms

Confusion or disorientation
Difficulty concentrating or focusing
Memory problems (short-term or long-term)
Slowed thinking or response time
Feeling “foggy” or dazed
Slurred speech
Poor judgment or decision-making
Trouble with language (finding words, understanding speech)
Difficulty with multitasking
Face blindness (difficulty recognising people)
Time blindness (difficulty managing or keeping up with time)
Vegetative state

Emotional & Behavioural Symptoms

Irritability or mood swings
Anxiety or panic
Depression or sadness
Agitation or aggression
Lack of motivation
Personality changes
Social withdrawal
Emotional numbness or detachment

Sleep-related Symptoms

Sleeping more than usual
Difficulty falling asleep
Sleeping less than usual
Daytime drowsiness

Severe Symptoms

These symptoms typically present during what is referred to as a flare-up, which represents an acute exacerbation of the individual’s existing symptoms, the most common during flares are below, however, flares can often be a manifestation of all of your symptoms and in most cases, that is almost all the symptoms of TBI, simultaneously:

Prolonged unconsciousness or coma
Inability to wake up from sleep
Profound confusion
Repeated vomiting or nausea
Slurred speech
Loss of motor function
Seizures or convulsions
Persistent vegetative state

Traumatic brain injury (TBI) is a complex condition with symptoms that vary from patient to patient. However, it is universally recognised that TBI significantly impacts an individual’s life and overall well-being.

What is Psilocybin?

Psilocybin is a psychedelic compound present in over 180 species of mushrooms, commonly referred to as “magic mushrooms.” Upon ingestion, psilocybin is metabolized by the body into psilocin, which is the substance responsible for its psychoactive effects. Psilocin primarily interacts with the brain’s serotonin receptors, especially the 5-HT2A receptor, resulting in alterations in perception, mood, and cognition.

How does Psilocybin work?

Psilocybin’s effects begin within 20 to 40 minutes of ingestion and can last 4 to 6 hours. Here’s how it works on a neurological level:

Serotonin Activation: Psilocin interacts with serotonin receptors, resulting in modified neural communication, particularly in regions associated with mood regulation, cognitive processes, and self-awareness.
Default Mode Network (DMN) Suppression: The DMN, a neural network implicated in self-referential thoughts and rumination, experiences suppression during psilocybin administration. This “reset” mechanism is proposed to have therapeutic potential for disorders such as depression and PTSD.
Neuroplasticity: Most notably, psilocybin has been shown to promote neurogenesis and synaptogenesis — the development of new neurons and synaptic connections. This property is of significant importance in the context of recovery from brain injuries.

What Conditions Can Psilocybin Treat?

Clinical trials and research suggest that psilocybin shows promise in treating:

Depression (especially treatment-resistant depression)
Anxiety, including end-of-life anxiety in terminal illness
Post-Traumatic Stress Disorder (PTSD)
Obsessive-Compulsive Disorder (OCD)
Addictions (alcohol, nicotine, etc.)
Cluster headaches and potentially chronic pain

While psilocybin is not yet an FDA-approved treatment for TBI, emerging preclinical and clinical research suggests it may support brain healing in several ways, which for the sake of brevity will be listed below.

Why does Psilocybin work?

Unlike traditional psychiatric medications that blunt symptoms, psilocybin appears to facilitate a psychological and neurological reset. Here’s why it’s significant:

Deep Emotional Processing: Under guided therapy, individuals often confront and release repressed trauma or entrenched thought patterns.
Increased Brain Connectivity: Brain scans during a psilocybin experience show heightened communication between brain regions that don’t usually “talk,” enabling new perspectives and insights.
Lasting Change: Even a single dose, combined with therapy, can yield lasting improvements in mood and mental health, sometimes for months.

How Psilocybin may help with TBI patients?

Neuroplasticity: Psilocybin may promote brain repair by facilitating the growth of dendrites and synaptic connections, aiding in the reorganization of the brain post-injury.
Anti-Inflammatory Effects: Traumatic Brain Injury (TBI) often results in prolonged inflammation. Research in animal models has demonstrated that psilocybin can reduce neuroinflammation, potentially safeguarding neurons from additional harm.
Mood and Cognitive Improvement: Individuals with TBI frequently suffer from depression, anxiety, and PTSD-like symptoms. Psilocybin-assisted therapy has exhibited significant benefits in ameliorating these conditions within non-TBI populations.
Increased Brain Connectivity: Functional MRI studies indicate that psilocybin enhances communication between brain regions, which may help to compensate for damaged neural pathways following TBI.

Disclaimer

Psilocybin medication is a controlled substance in many regions globally and should only be used legally and under the supervision of qualified professionals. Currently, the use of psilocybin for traumatic brain injury (TBI) remains an experimental area, necessitating further clinical trials to fully assess its efficacy and safety for this specific application. Psilocybin as medicine, represents a significant advancement in mental and neurological health. Its potential to promote cognitive healing and possibly regenerate brain tissue places it at the forefront of medical innovation, particularly in the context of TBI treatment.

Patient X’s story

“Sometimes I feel this wave of guilt when it hits, because in an instant, my ability to communicate just slips away. Even saying a simple goodbye becomes nearly impossible. People often want to linger, to share a few last words, but I can’t do that. Every sound feels like a knife in my brain. When I say goodbye, I have to walk away immediately, no small talk, no extra goodbyes: because even a few more seconds of stimulation can break me. And if I’m out somewhere, I still have to find a way to get home through the chaos in my head. I try to explain this to people, but most don’t really understand. So, I walk away… and carry the guilt with me.”

– Patient X

Firstly, we would like to express our sincere gratitude to Patient X for bravely coming forward to share her personal journey using psilocybin as medication. Her willingness to speak openly plays a vital role in raising awareness about the potential benefits of psilocybin as medicine and in supporting the advancement of this treatment within the UK.

Patient X is a woman in mid 30s living in the UK. Following a significant fall, she sustained a severe blow to the head and was initially diagnosed with a concussion. Unfortunately, due to recurrent fainting episodes and repeated head trauma in the weeks and months that followed, her condition progressed into a traumatic brain injury (TBI).

Patient X experienced the following symptoms: –

Headache (persistent or worsening)
Nausea or vomiting
Loss of appetite
Fatigue or drowsiness
Fainting
Loss of consciousness (seconds to hours)
Loss of motor functions
Loss of co-ordination
Dizziness or balance problems
Sensitivity to light or noise
Blurred or double vision
Ringing in the ears (tinnitus)
Weakness or numbness in fingers and toes
Loss of coordination
Confusion or disorientation
Difficulty concentrating or focusing
Memory problems (short-term or long-term)
Slowed thinking or response time
Feeling “foggy” or dazed
Slurred speech
Poor judgment or decision-making
Trouble with language (finding words, understanding speech)
Difficulty with multitasking
Face blindness (difficulty recognising people)
Time blindness (difficulty managing or keeping up with time)
Vegetative state
Irritability or mood swings
Anxiety or panic
Depression or sadness
Lack of motivation
Social withdrawal
Emotional numbness or detachment
Difficulty falling asleep
Sleeping less than usual
Daytime drowsiness

When Patient X experiences a flare-up, it is often a culmination of all the symptoms she battles daily sensory overload, migraines, cognitive fatigue, and overwhelming neurological distress. In her own words:

“There were days I truly believed my brain was trying to break free from my skull. The pain was so relentless, all I could do was wrap my hands and towels around my head, rocking on the bathroom floor, crying and throwing up. I couldn’t open my eyes or bear the faintest sound, everything was too much. A car door slamming outside felt like an explosion inside my head. Every bit of light, every noise, every moment felt like my body was betraying me, and all I could do was survive it.”

– Patient X

In the beginning, Patient X was unable to function. The only thing she could do was lie motionless in a dark, silent room, sipping water slowly, with a bucket by her side to vomit into. The pain was so overwhelming, so all-consuming, that even the smallest light or sound felt like it would shatter her.

On the rare days she managed to move around, her mind would betray her. She couldn’t trust what she saw, what she heard, or what she thought she remembered. Sometimes she wouldn’t register cars on the road. Other times, she would see or hear things that simply weren’t there. These hallucinations blurred the line between reality and fear, and she became terrified, not just of the world, but of her own mind.

What made it worse was the silence…the crushing isolation that came from losing the ability to communicate. Trying to speak to others became overwhelming. Words failed her. Simple conversations would leave her confused, and she could feel the frustration in people’s eyes as they tried to make sense of her pauses, her uncertainty, her jumbled sentences. Eventually, she stopped trying. She was too scared to open her mouth, too scared of being misunderstood again. At her lowest point, Patient X says she could no longer even trust herself to make basic decisions.

“I didn’t feel like I had capacity,” she said. “My brain wasn’t working, and my GP just told me to take more anti-inflammatories. But all they did was dull the pain for a moment; the migraines would lift slightly, but the rest of me was still falling apart.”

– Patient X

The cruellest part was that every time she fainted, again and again, she would hit her head, damaging her brain further. There was no plan. No safety net. No real help.

“I was lost,” she says. “I was broken. I didn’t know where to go for support. The people who were supposed to care didn’t. And I found myself curled up in the corner of my bathroom, just rocking back and forth, crying, and throwing up. I didn’t know how much longer I could survive like that.”

– Patient X

It was during one of her lowest moments that Patient X began to seriously research psilocybin. A friend had mentioned it to her before, but at the time, she had dismissed the idea. She felt sceptical, how could something so stigmatized, so unconventional, possibly help? But she was desperate. She was tired of merely existing, tired of living like a ghost in her own life.

With nowhere else to turn, she began exploring online support groups, cautiously reaching out to others who had used psilocybin to manage complex, chronic conditions. What she found surprised her. She connected with people living with multiple sclerosis, fibromyalgia, and traumatic brain injuries, conditions with overlapping neurological symptoms, who spoke openly about their experiences. Many described significant improvements: clearer thinking, less pain, fewer flare-ups, a return of a sense of self. For the first time in a long while, she felt a glimmer of hope.

Encouraged by these conversations, Patient X began to consider trying psilocybin herself. But she didn’t want to do it alone. She needed guidance, oversight; someone in the medical field to help her navigate this step safely. Psilocybin, after all, was still in the early stages of research in the UK. It was a leap into the unknown. She needed to feel some sense of safety, some reassurance that she wouldn’t be left to manage the experience on her own.

After extensive searching, she found a clinic in the United States willing to support her. With trembling hands and a racing heart, she began the process of treatment. She was terrified, but she felt she had no other choice. When every conventional option had failed, and the system had left her behind, this was the one path that still held a thread of hope. To her astonishment, Patient X felt a profound sense of relief almost immediately after beginning psilocybin treatment. For the first time in months, her symptoms began to lift. The medications didn’t “cure” her, but they gave her something she hadn’t felt in a long time: control, clarity, and a glimpse of her old self.

It’s important to understand that psilocybin isn’t taken daily. The treatment requires rest periods, break days, to allow the brain to integrate and recover. On those break days, Patient X often still struggled. But on dosing days, she came alive. It felt like someone had switched the lights back on in her brain. And while she wasn’t back to 100%, regaining even 75% of her cognitive function was something she never thought possible. Through careful trial and error, Patient X discovered the right dosage for her needs. She eventually settled on 250 mg every other day as her baseline. In the early stages, however, flare-ups, those intense, unbearable days, required a much higher dose. On those days, only 1 gram would alleviate the symptoms. Her nurse was concerned, as this is considered a high dose, but nothing lower had any effect.

Encouragingly, within a month of treatment, her need for high doses began to diminish. What once required 1 gram could be managed with 500 mg, and then just 250 mg. Over time, her brain began to respond and stabilize. Now, six months into treatment, the changes are remarkable. Where she once experienced debilitating flare-ups every single day, they now occur weekly, or even every other week, and usually last only one or two days. These are managed with a dose of 200–250 mg. Her typical regimen has also adjusted, with maintenance doses between 100–150 mg on regular days.

One of the most surprising milestones came around the third month: she began to forget to take her medication. As strange as that sounds, it was a major sign of progress. “When you’re really unwell, your medication is all you can think about, you’re desperate for relief,” she explains. “So, when I started forgetting, it meant the pain wasn’t screaming at me anymore.” Her nurse reminded her that true stability in traumatic brain injury recovery can take 9–12 months, sometimes longer. Even on better days, she was encouraged to maintain consistency with her dosing. “Just because you’re not in crisis doesn’t mean your brain doesn’t still need support,” her nurse advised.

Now, at the six-month mark, Patient X is cautiously hopeful. While many symptoms still linger, they’ve shifted from severe to moderate, or even mild on some days. She understands that full recovery may never be possible, and that some level of struggle will likely remain. Still, her dream remains alive: to reach a point where flare-ups come just once a month, not every week. A life that, while not perfect, is liveable. And for the first time in a long time, she believes it might actually be within reach.

Patient X explained, she experienced the following side effects, shortly after taking the medications:

Nausea (higher doses)
Itchy Brain & Skin
Tingling in the body
Seeing stars and/or blurred vision (on higher doses)
Hot flashes
Areas of your body that are in pain become on fire and stimulated

Patient X expresses uncertainty about whether their symptoms are typical, as there is limited research available for cross-referencing. This uncertainty has occasionally caused them significant anxiety and doubt regarding their current course of action. Despite these concerns, Patient X continues with the treatment due to notable improvements in their overall well-being.

At present, Patient X is in a far better place. She continues her psilocybin treatment and, gradually, has begun to reclaim parts of her life that once felt lost, her ability to connect with others, to participate in conversations, and to simply feel present in the world around her.

But it’s important to remember that this is still a brain injury. Recovery isn’t linear, and symptoms don’t just disappear. Every day remains a challenge. Simple tasks can demand immense cognitive effort, and by the end of the day, she’s completely drained; mentally and physically. Socialising after a certain hour becomes nearly impossible.

“Early in the morning and later in the evening, I’m just not compos mentis,” she shares. “My brain doesn’t function like it used to. These are the windows I’m still working on.” Yet the progress she’s made is undeniable. In the past, her brain would begin to shut down by 6 p.m., leaving her unable to hold a conversation for more than 30 minutes without descending into confusion and brain fog. Now, she can often stay engaged until 8 or 9 p.m., and hold meaningful discussions for up to 90 minutes before cognitive fatigue sets in. “That might not sound like a big deal to most people,” she says, “but to me, it’s everything. It means my brain is healing, slowly but surely. And that gives me hope” explains patient X.

“People don’t realize that your brain is like a muscle and when you live with a brain injury, every thought, every conversation, every task takes effort. You can get through the day seeming ‘okay,’ but by the end, the weight of it all crashes down. Even now, after work, I’m hit with a brutal migraine almost every evening. I have to lay in the dark for an hour just to calm the storm in my head. And some days, I don’t even make it that far, I just crawl into bed, no matter what time it is, because my brain has reached its limit. It’s done. And so am I.”

– Patient X

Takeaway / Last Thoughts

Patient X’s story is one of quiet courage, resilience, and determination in the face of a healthcare system that, for too long, has offered too little. Through her journey with psilocybin treatment, she has begun to reclaim her life, bit by bit, day by day. From lying in a dark room, unable to speak, think, or move without pain, to now engaging in meaningful conversations, working, and slowly rebuilding her social life, her progress is nothing short of remarkable.

But her story is not just about personal healing—it is also a call to action!!!!

It is no longer acceptable to ignore the growing body of evidence and the voices of patients who are finding relief through psilocybin. To continue pretending that people aren’t already using this treatment, often in desperation, often in silence; is a disservice to those who need medical oversight and protection the most. Psilocybin remains, in the UK, a Schedule 1 substance, meaning it is considered to have no medicinal value. And yet, real people like Patient X, are experiencing tangible, life-changing benefits.

Patient X considers herself incredibly fortunate. She was able to access support through a qualified healthcare provider abroad something that should never be a privilege, but standard care. Most people aren’t this lucky. Many are left with no option but to source psilocybin from the unregulated market, or attempt to grow their own, navigating dosing, safety, and treatment protocols without any medical guidance simply because they cannot afford otherwise.

“Healthcare should be safe, supported, and professional,” she says. “It shouldn’t involve putting your life at risk, experimenting in isolation, or fearing legal consequences just for trying to survive.”

She is now calling on the UK government to open its eyes—and its heart—to patients like her. The evidence is mounting. The patient voices are growing louder. And the need is urgent. It’s time to invest in serious research, expand clinical trials, and reschedule psilocybin so that it can be safely accessed under medical supervision.

Because healing should never be illegal. And no one should have to suffer in silence when hope is within reach….

References

Disclaimer – EthVida is not a healthcare provider, we offer awareness in the form of education, signposting and advocacy for plant-based medicines. Currently, the use of psilocybin for traumatic brain injury (TBI) remains an experimental area, necessitating further clinical trials to fully assess its efficacy and safety for this specific application.